Kitea Health Soars to Silicon Valley

Kitea Health, has achieved a significant milestone with co-founder Natalia Lopez securing a spot to represent New Zealand at the prestigious 2024 Startup World Cup. This global competition will take place in Silicon Valley where Natalia will showcase the innovative Kitea System to a panel of over 2,500 investors, Venture Capital firms (including Pegasus Investments), and interact with other promising startups from around the world.

The Kitea System, developed by Kitea Health, is a groundbreaking solution that aims to revolutionize healthcare by providing accessible and affordable remote monitoring for patients. The system empowers individuals to manage their health proactively, reducing the burden on healthcare systems and improving overall outcomes.

Natalia Lopez's selection to represent New Zealand at the Startup World Cup is a testament to Kitea Health's groundbreaking work and Natalia's exceptional leadership. This opportunity will provide a global platform to showcase the Kitea System to potential investors, partners, and industry leaders, paving the way for further growth and expansion.

As Natalia prepares to embark on this exciting journey to Silicon Valley, Kitea Health is eager to see the impact that the Startup World Cup will have on the company's future. The exposure and connections gained from this prestigious competition will undoubtedly play a crucial role in driving innovation and advancing healthcare solutions.

Check out more of what the Media (The Post and Stuff News) has to say about Kitea Health's recognition.

KiwiNet Award Category: PwC Breakthrough Project

Another recognition, with another opportunity to showcase the amazing work Kitea Health is doing.

Kitea Health has been nominated for the prestigious 2024 KiwiNet Research Commercialization Awards. Award Category: PwC Breakthrough Project.

The team from Kitea Health has developed a product that can proactively monitor changes in intracranial pressure for patients with hydrocephalus. While shunts are currently used to manage hydrocephalus, they have a staggering 50% failure rate. It's often unclear to patients, who are often children and their families, whether an everyday symptom such as a headache or tiredness is a shunt failure or not.

This award also highlights the company's history and journey. Starting with 15 years of research from the implantable device group within Auckland Bioengineering Institute at the University of Auckland, driven by a clinical need, Kitea Health is now a company that is making a difference. This is also an opportunity for the company to pay tribute to the supporters, employees, patients, and their family.

Best Design Awards Finalist: Kitea Health Wand

Kitea Health has been recognized as a finalist in the prestigious 2024 Best Design Awards for Non-Consumable Products. The company's innovative Kitea Health Wand has impressed the judges with its design and potential impact.

Designed by Daniel McCormick, Senior Research Fellow at the Auckland Bioengineering Institute and Head of Engineering at Kitea Health, the Wand is a groundbreaking innovation empowering patients with chronic conditions like hydrocephalus to remotely manage their health. This award nomination highlights the exceptional dedication and expertise of the Kitea Health team.